Literature DB >> 1927917

Usefulness of the delta HA interval to accurately distinguish atrioventricular nodal reentry from orthodromic septal bypass tract tachycardias.

J M Miller1, M E Rosenthal, C D Gottlieb, J A Vassallo, M E Josephson.   

Abstract

Surface electrocardiographic criteria may be inadequate to distinguish some cases of atrioventricular (AV) nodal reentrant supraventricular tachycardia (SVT) from those with orthodromic SVT incorporating a posterior septal bypass tract (orthodromic SVT) because of similarities in P-wave morphology and timing during SVT. Invasive electrophysiologic studies may occasionally leave uncertainty in the correct diagnosis, using currently accepted criteria. A new criterion for distinguishing these 2 forms of SVT was therefore devised and tested based on differences in the sequence of activation of the His bundle and atrium during SVT and ventricular pacing. Eighty-four patients underwent invasive electrophysiologic studies (60 with proved AV nodal SVT, 24 with proved orthodromic SVT), during which His to atrial (HA) intervals were measured during SVT as well as ventricular pacing at the same rate. The newly devised criterion, the delta HA interval (HApace-HAsvt) was found to accurately distinguish AV nodal SVT (delta HA greater than 0 ms) from orthodromic SVT (delta HA less than -27 ms). An intermediate value of delta HA = -10 ms was chosen which had a 100% sensitivity, specificity and predictive accuracy in differentiating the 2 forms of SVT. A clear retrograde His potential during ventricular pacing, which is essential for application of this criterion, was present in 78 of 84 (93%) cases. In summary, patients with delta HA intervals greater than -10 ms separate AV nodal reentry from orthodromic SVT incorporating a septal bypass tract, and no overlap exists between the 2 groups. This criterion may be useful in differentiating the mechanism of SVT in cases in which distinction is not possible by other methods.

Entities:  

Mesh:

Year:  1991        PMID: 1927917     DOI: 10.1016/0002-9149(91)90492-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  Improvement of atrioventricular conduction following catheter ablation of atrioventricular nodal reentry tachycardia in a patient with a prolonged PR interval.

Authors:  Seigo Yamashita; Teiichi Yamane; Seiichiro Matsuo; Keiichi Ito; Ryohsuke Narui; Mika Hioki; Shin-ichi Tanigawa; Michifumi Tokuda; Keiichi Inada; Taro Date; Ken-ichi Sugimoto; Michihiro Yoshimura
Journal:  Heart Vessels       Date:  2012-02-22       Impact factor: 2.037

2.  Successful catheter ablation of a slow AV-nodal pathway from the left posteroseptal region.

Authors:  M Wieczorek; R Höltgen; I Djajadisastra
Journal:  Z Kardiol       Date:  2005-08

3.  Mark E Josephson: Clinical Investigator.

Authors:  John M Miller
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-04

4.  Variability of the VA interval at tachycardia induction: a simple method to differentiate orthodromic reciprocating tachycardia from atypical atrioventricular nodal reentrant tachycardia.

Authors:  Claudio Hadid; Leonardo Celano; Darío Di Toro; Edgar Antezana-Chavez; Sebastián Gallino; Gustavo Iralde; David Calvo; Pablo Ávila; Leonardo Atea; Sergio Gonzalez; Sebastián Maldonado; Carlos Labadet
Journal:  J Interv Card Electrophysiol       Date:  2022-09-24       Impact factor: 1.759

5.  Classification, Electrophysiological Features and Therapy of Atrioventricular Nodal Reentrant Tachycardia.

Authors:  Demosthenes G Katritsis; Mark E Josephson
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-08

6.  Principles of entrainment: diagnostic utility for supraventricular tachycardia.

Authors:  George D Veenhuyzen; F Russell Quinn
Journal:  Indian Pacing Electrophysiol J       Date:  2008-02-01

7.  Outcomes of Different Ablation Approaches for Para-Hisian Accessory Pathway and Ablation Safety at Each Site.

Authors:  Jian-du Yang; Qi Sun; Xiao-Gang Guo; Gong-Bu Zhou; Xu Liu; Hui-Qiang Wei; Hai-Yang Xie; Jian Ma
Journal:  Front Cardiovasc Med       Date:  2022-01-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.